Exploratory Study on Modifiers of the Effect of Nalmefene in Reducing Alcohol Consumption in Patients with Alcoholism on the Basis of Genetic Factors
Latest Information Update: 23 Nov 2022
At a glance
- Drugs Nalmefene (Primary)
- Indications Alcoholism
- Focus Pharmacodynamics
- Sponsors Otsuka Pharmaceutical
- 21 Nov 2022 Planned End Date changed from 30 Sep 2021 to 30 Sep 2023.
- 06 Aug 2021 New trial record